These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12953853)

  • 1. PROGRESS results: implementation in stroke guidelines.
    Donnan GA
    J Hypertens Suppl; 2003 Jun; 21(5):S25-8. PubMed ID: 12953853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of PROGRESS: questions and answers.
    Chalmers J; Adams HP; Donnan GA; Fox K; MacMahon S; Mancia G; Tzourio C
    J Hypertens Suppl; 2003 Jun; 21(5):S21-4. PubMed ID: 12953852
    [No Abstract]   [Full Text] [Related]  

  • 3. Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.
    Chalmers J; MacMahon S
    J Hypertens Suppl; 2003 Jun; 21(5):S9-14. PubMed ID: 12953850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme inhibitors. Perindopril pROtection aGainst REcurrent Stroke Study.
    Psaty BM; Weiss NS; Furberg CD
    Am J Hypertens; 2002 May; 15(5):472-4. PubMed ID: 12022252
    [No Abstract]   [Full Text] [Related]  

  • 5. Trials on blood pressure-lowering and secondary stroke prevention.
    Chalmers J
    Am J Cardiol; 2003 May; 91(10A):3G-8G. PubMed ID: 12781902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in secondary prevention of stroke with PROGRESS. The perindopril protection against recurrent stroke study.
    Schiffrin EL
    Curr Hypertens Rep; 2002 Feb; 4(1):39-40. PubMed ID: 11790290
    [No Abstract]   [Full Text] [Related]  

  • 7. The PROGRESS trial three years later: time for a balanced report of effectiveness.
    Wennberg R; Zimmermann C
    BMJ; 2004 Oct; 329(7472):968-70. PubMed ID: 15499116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of the month. Secondary prevention of cerebrovascular accident with perindopril: the PROGRESS study].
    Scheen AJ
    Rev Med Liege; 2001 Nov; 56(11):792-5. PubMed ID: 11789395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients?
    Schiffrin EL
    Circulation; 2005 Sep; 112(11):1525-6. PubMed ID: 16157782
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial.
    Chapman N; Huxley R; Anderson C; Bousser MG; Chalmers J; Colman S; Davis S; Donnan G; MacMahon S; Neal B; Warlow C; Woodward M;
    Stroke; 2004 Jan; 35(1):116-21. PubMed ID: 14671247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertension in the acute phase and in the secondary prevention of stroke].
    Arquizan C
    Rev Prat; 2004 Mar; 54(6):637-40. PubMed ID: 15222615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
    Bath P
    Stroke; 2003 May; 34(5):1334-5. PubMed ID: 12702833
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood pressure reduction and ACE inhibition in secondary stroke prevention: mechanism uncertain.
    Davis SM; Donnan GA
    Stroke; 2003 May; 34(5):1335-6. PubMed ID: 12702835
    [No Abstract]   [Full Text] [Related]  

  • 14. The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular disease.
    Ratnasabapathy Y; Lawes CM; Anderson CS
    Drugs Aging; 2003; 20(4):241-51. PubMed ID: 12641480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cerebrovascular disease: Impact of INDANA meta-analysis and PROGRESS trial].
    Matsumoto M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():605-11. PubMed ID: 15179938
    [No Abstract]   [Full Text] [Related]  

  • 16. [PROGRESS].
    Hasegawa Y
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():396-401. PubMed ID: 16983776
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of perindopril in the prevention of stroke.
    Papadopoulos DP; Votteas V
    Recent Pat Cardiovasc Drug Discov; 2006 Nov; 1(3):283-9. PubMed ID: 18221093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conflicting evaluations of the PROGRESS Study].
    Hausberg M; Kosch M; Rahn KH
    Internist (Berl); 2003 May; 44(5):631-2. PubMed ID: 12966791
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan.
    Hasegawa Y; Yamaguchi T; Omae T; Woodward M; Chalmers J;
    Hypertens Res; 2004 Mar; 27(3):147-56. PubMed ID: 15080373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROGRESS: Prevention of Recurrent Stroke.
    Arima H; Chalmers J
    J Clin Hypertens (Greenwich); 2011 Sep; 13(9):693-702. PubMed ID: 21896153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.